Clinical Trials Logo

Clinical Trial Summary

The purpose of the clinical study is to evaluate efficacy of regular daily, 12 weeks, consumption of EpiCor syrup containing EpiCor and vitamin C in non-vaccinated children 1-6 years old on preventing episodes of the common cold and flu as well as on the severity of symptoms of the common cold and flu in case of their occurrence. Additionally, the study aims to assess the effect of EpiCor on the use of prescription drugs and changes of a selected biochemical marker. This is a double-blind, randomized, controlled multi-center clinical trial.


Clinical Trial Description

This is a double-blind, randomized, controlled multi-center clinical trial aiming to evaluate the effects of daily consumption of EpiCor with vitamin C, primarily on the incidence and, secondary, on the duration and severity of the common cold and influenza in children, compared to the effects of daily consumption of vitamin C alone. Healthy children aged 1-6 years old are included in the study after parents have provided informed consent for study participation. Children are divided in 3 age groups (1-2 year old, 3-4 years old, 5-6 years old) and randomized in one of the two groups (intervention or control) at a 1:1 ratio. Children eligible for participation are included in the study for 12 weeks. During this period, they visit the investigational center 3 times. During visit 1 (day 0) caregivers get familiarized with the purpose, course and procedures of the trial, provide written informed consent upon which investigator assesses child's suitability for participation and, for eligible children, a study participant number is provided and a randomization number is assigned; in addition, the investigator collects demographic information, data on vital signs, medical history, collects a sample for determination of salivary secretory immunoglobulin A (sIgA), provides caregivers with a Study Dairy and clear instructions regarding completion, consumption, storage and return of unused syrup, taking medication and other food supplements during the study, monitoring adverse events and measures to be taken in the event of serious adverse events, determines the daily dose of syrup to be taken based on child's age, supplies the caregiver with enough syrup and sets a date for next visit. Between visits, children take a prescribed dose of syrup once daily. Six weeks (visit 2) and 12 weeks (visit 3) after the first visit, children and caregivers visit the investigational center again. During these 2 visits, the investigator collects data on vital signs, reviews concomitant medication and the taking of other food supplements, collects sample for determination of salivary SIgA, reviews the Study Dairy, supplies the caregiver with new syrup and provides the same clear instructions as in visit 1. Caregivers are asked to complete the Study Dairy on daily basis and, each time a caregiver marks that a symptom is present, the Investigator receives a notification and reviews the symptoms and consequently confirms the episode of a common cold/flu. The Canadian Acute Respiratory Illness and Flu Scale (CARIFS) is used to assess the severity of symptoms of the common cold and flu in participating children and, in case of occurrence of cold/flu symptoms, caregivers are asked to complete the form twice a day for the first seven days, once on day 10 and once on day 14. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04093206
Study type Interventional
Source Cargill
Contact
Status Completed
Phase N/A
Start date December 22, 2017
Completion date March 28, 2019

See also
  Status Clinical Trial Phase
Completed NCT05492370 - Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children N/A
Completed NCT00331929 - Respiratory Health Study of Children in Kiryat Tivon N/A
Completed NCT00934713 - The Effect of Montelukast Treatment in Wheezy Infants Phase 4
Recruiting NCT02913365 - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis N/A
Completed NCT01532180 - Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA) N/A
Completed NCT04081961 - Feasibility Study to Use Biosensing Devices to Monitor PA and Resp. Function in Smokers w and w/o Resp. Symptoms/COPD
Recruiting NCT05837585 - The Effectiveness of Air Quality Sensor in Elderly Residential Setting N/A
Recruiting NCT00328029 - Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population Phase 2
Completed NCT02994680 - Cardiopulmonary Outcomes and Household Air Pollution Trial N/A
Active, not recruiting NCT03043911 - Improved Patient Safety Through Continuous Bi-channel RR and SpO2 Monitoring With Masimo Patient SafetyNet N/A
Completed NCT01796925 - Targeted Hypoglossal Neurostimulation Study #2 N/A
Completed NCT02538601 - Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster N/A
Completed NCT00718133 - The Effect of Air Pollution on Lung Health Among Children Living in Haifa Bay Region, Israel N/A
Completed NCT00717899 - The Effect of Air Pollution on Lung Health Among School Children Living in Haifa Bay Region N/A
Completed NCT02457780 - Stress Management Program for World Trade Center (WTC) Responders N/A
Terminated NCT02821650 - A Study to Test the Impact of an Improved Chulha on Respiratory Health of Women and Children in Indian Slums N/A